nach oben

Erschienen in:

09.05.2018 | Review articles

Inherited primary arrhythmia disorders: cardiac channelopathies and sports activity

verfasst von: S. Marrakchi, I. Kammoun, E. Bennour, L. Laroussi, M. Ben Miled, S. Kachboura

Erschienen in: Herz | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Sudden cardiac death (SCD) in an apparently healthy individual is a tragedy. It is important to identify the cause of death and to prevent SCD in potentially at-risk family members. Inherited primary arrhythmia disorders are associated with exercise-related SCD. Despite the well-known benefits of exercise, exercise restriction has been a historical mainstay of therapy for these conditions. However, since familiarity with inherited arrhythmia conditions has increased and patients are often children and young adults, it is necessary to reassess the treatment guidelines regarding exercise constraints. The aim of this review is to analyze the risk of exercise-induced SCD in patients with inherited cardiac conditions and explore the challenges faced when advising patients about exercise limitations. We searched for publications on cardiac channelopathies in PubMed with the following medical subject headings (MeSH): “long QT syndrome”; “short QT syndrome”; “Brugada syndrome”; and “catecholaminergic polymorphic ventricular tachycardia”. The abstracts of these articles were scanned, and articles of relevance, along with pertinent references, were read in full. The analysis was restricted to reports published in English. The findings of this analysis suggest that exercise with low-to-moderate cardiovascular demand may be possible under regular clinical follow-up in inherited primary arrhythmia disorders. Recent data show that patients with inherited primary arrhythmia disorders are at low risk for events once a comprehensive treatment program has been established. Recreational activity is likely safe for these individuals, with personalized management based on individual patient preferences and priorities.

Toresdahl BG, Rao AL, Harmon KG, Drezner JA (2014) Incidence of sudden cardiac arrest in high school student athletes on school campus. Heart Rhythm 11(7):1190–1194PubMed

Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO (2009) Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 119(8):1085–1092PubMed

Ostby SA, Bos JM, Owen HJ, Wackel PL, Cannon BC, Ackerman MJ (2016) Competitive sports participation in patients with catecholaminergic polymorphic ventricular tachycardia. JACC Clin Electrophysiol 2(3):253–262PubMed

Harmon KG, Asif IM, Maleszewski JJ et al (2015) Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes CLINICAL PERSPECTIVE. Circulation 132(1):10–19PubMedPubMedCentral

Hammond-Haley M, Patel RS, Providência R, Lambiase PD (2016) Exercise restrictions for patients with inherited cardiac conditions: current guidelines, challenges and limitations. Int J Cardiol 209:234–241PubMed

Behere SP, Weindling SN (2015) Inherited arrhythmias: the cardiac channelopathies. Ann Pediatr Cardiol 8(3):210–220PubMedPubMedCentral

Napolitano C, Bloise R, Priori SG (2006) Long QT syndrome and short QT syndrome: how to make correct diagnosis and what about eligibility for sports activity. J Cardiovasc Med 7(4):250–256

Haskell WL, Lee IM, Pate RR et al (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39(8):1423–1434PubMed

Graham I, Atar D, Borch-Johnsen K et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 14(Suppl 2):E1–E40PubMed

10.

La Gerche A, Schmied CM (2013) Atrial fibrillation in athletes and the interplay between exercise and health. Eur Heart J 34(47):3599–3602PubMed

11.

Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G (2003) Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42(11):1959–1963PubMed

12.

Lombardi F, Malfatto G, Belloni A, Garimoldi M (1987) Effects of sympathetic activation on ventricular ectopic beats in subjects with and without evidence of organic heart disease. Eur Heart J 8(10):1065–1074PubMed

13.

Maron BJ, Chaitman BR, Ackerman MJ, Bayés de Luna A, Corrado D, Crosson JE et al (2004) Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 109(22):2807–2816PubMed

14.

Mitchell JH, Haskell W, Snell P, Van Camp SP (2005) Task force 8: classification of sports. J Am Coll Cardiol 45(8):1364–1367PubMed

15.

Mitchell JH, Maron BJ, Epstein SE (1984) 16th Bethesda Conference: cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. J Am Coll Cardiol 6(6):1186–1232

16.

Mitchell JH, Haskell WL, Raven PB (1994) Classification of sports. J Am Coll Cardiol 24(4):864–866PubMed

17.

Levine BD, Baggish AL, Kovacs RJ et al (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 1: classification of sports: dynamic, static, and impact: a scientific statement from the American Heart Association and American College of Cardiology. Circulation 132(22):e262–e266PubMed

18.

Mitchell JHJB (1990) Wolffe memorial lecture. Neural control of the circulation during exercise. Med Sci Sports Exerc 22(2):141–154PubMed

19.

Mitchell JH, Victor RG (1996) Neural control of the cardiovascular system: insights from muscle sympathetic nerve recordings in humans. Med Sci Sports Exerc 28(10 Suppl):S60–S69PubMed

20.

Mitchell JH, Schibye B, Payne FC, Saltin B (1981) Response of arterial blood pressure to static exercise in relation to muscle mass, force development, and electromyographic activity. Circ Res 48(6 Pt 2):I70–I75PubMed

21.

Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 66(21):2424–2428PubMed

22.

McGuire DK, Levine BD, Williamson JW, Snell PG, Blomqvist CG, Saltin B et al (2001) A 30-year follow-up of the Dallas Bedrest and Training Study: I. Effect of age on the cardiovascular response to exercise. Circulation 104(12):1350–1357PubMed

23.

Fu Q, Levine BD (2005) Cardiovascular response to exercise in women. Med Sci Sports Exerc 37(8):1433–1435PubMed

24.

Pelliccia A, Fagard R, Bjørnstad HH et al (2005) Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26(14):1422–1445PubMed

25.

Heidbüchel H, Corrado D, Biffi A et al (2006) Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 13(5):676–686PubMed

26.

Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G et al (2009) Prevalence of the congenital long-QT syndrome. Circulation 120(18):1761–1767PubMedPubMedCentral

27.

Earle N, Crawford J, Smith W, Hayes I, Shelling A, Hood M et al (2013) Community detection of long QT syndrome with a clinical registry: an alternative to ECG screening programs? Heart Rhythm 10(2):233–238PubMed

28.

Uhm JS, Hwang IU, Oh YS et al (2011) Prevalence of electrocardiographic findings suggestive of sudden cardiac death risk in 10,867 apparently healthy young Korean men. Pacing Clin Electrophysiol 34(6):717–723PubMed

29.

Hayashi K, Fujino N, Uchiyama K, Ino H, Sakata K, Konno T et al (2009) Long QT syndrome and associated gene mutation carriers in Japanese children: results from ECG screening examinations. Clin Sci 117(12):415–424

30.

Murakoshi N, Aonuma K (2013) Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J 77(10):2419–2431PubMed

31.

Roden DM, Spooner PM (1999) Inherited long QT syndromes: a paradigm for understanding arrhythmogenesis. J Cardiovasc Electrophysiol 10(12):1664–1683PubMed

32.

Schwartz PJ, Locati E (1985) The idiopathic long QT syndrome: pathogenetic mechanisms and therapy. Eur Heart J 6(Suppl D):103–114PubMed

33.

Kaufman ES (2009) Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart Rhythm 6(8):S51–S55PubMed

34.

Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K et al (2006) The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 113(6):783–790PubMed

35.

Hobbs JB, Peterson DR, Moss AJ, McNitt S, Zareba W, Goldenberg I et al (2006) Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 296(10):1249–1254PubMed

36.

Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al (2013) Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 15(10):1389–1406PubMed

37.

Obeyesekere MN, Antzelevitch C, Krahn AD (2015) Management of ventricular arrhythmias in suspected channelopathies. Circ Arrhythm Electrophysiol 8(1):221–231PubMed

38.

Tester DJ, Will ML, Haglund CM, Ackerman MJ (2006) Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol 47(4):764–768PubMed

39.

Schwartz PJ, Crotti L (2007) Cardiac arrhythmias of genetic origin are important contributors to sudden infant death syndrome. Heart Rhythm 4(6):740–742PubMed

40.

Digby GC, Pérez Riera AR, Barbosa Barros R et al (2011) Acquired long QT interval: a case series of multifactorial QT prolongation. Clin Cardiol 34(9):577–582PubMedPubMedCentral

41.

Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M et al (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348(19):1866–1874PubMed

42.

Sakaguchi T, Shimizu W, Itoh H, Noda T, Miyamoto Y, Nagaoka I et al (2008) Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome. J Cardiovasc Electrophysiol 19(8):794–799PubMed

43.

Antzelevitch C (2007) Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace 9(Suppl 4):iv4–iv15PubMed

44.

Tomaselli GF, Barth AS (2016) Ion channel diseases: an update for 2016. Curr Treat Options Cardiovasc Med. https://doi.org/10.1007/s11936-016-0442-1 CrossRefPubMed

45.

Funada A, Hayashi K, Ino H, Fujino N, Uchiyama K, Sakata K et al (2008) Assessment of QT intervals and prevalence of short QT syndrome in Japan. Clin Cardiol 31(6):270–274PubMedPubMedCentral

46.

Maury P, Extramiana F, Sbragia P, Giustetto C, Schimpf R, Duparc A et al (2008) Short QT syndrome. Update on a recent entity. Arch Cardiovasc Dis 101(11–12):779–786PubMed

47.

Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R et al (2003) Short QT syndrome: a familial cause of sudden death. Circulation 108(8):965–970PubMed

48.

Gussak I, Brugada P, Brugada J et al (2000) Idiopathic short QT interval: a new clinical syndrome? Cardiology 94(2):99–102PubMed

49.

Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A et al (2005) A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96(7):800–807PubMed

50.

Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M et al (2004) Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109(1):30–35PubMed

51.

Bellocq C, van Ginneken ACG, Bezzina CR, Alders M, Escande D, Mannens MMAM et al (2004) Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109(20):2394–2397PubMed

52.

Antzelevitch C, Pollevick GD, Cordeiro JM et al (2007) Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115(4):442–449PubMedPubMedCentral

53.

Schimpf R, Bauersfeld U, Gaita F, Wolpert C (2005) Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2(4):416–417PubMed

54.

Schimpf R, Wolpert C, Bianchi F et al (2003) Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery. J Cardiovasc Electrophysiol 14(12):1273–1277PubMed

55.

Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calò L et al (2004) Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 43(8):1494–1499PubMed

56.

Milberg P, Tegelkamp R, Osada N et al (2007) Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. J Cardiovasc Electrophysiol 18(6):658–664PubMed

57.

Ackerman MJ, Priori SG, Willems S et al (2011) HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13(8):1077–1109PubMed

58.

Patel C, Antzelevitch C (2008) Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome. Heart Rhythm 5(4):585–590PubMedPubMedCentral

59.

Gupta P, Patel C, Patel H et al (2008) T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 41(6):567–574PubMed

60.

Anttonen O, Väänänen H, Junttila J, Huikuri HV, Viitasalo M (2008) Electrocardiographic transmural dispersion of repolarization in patients with inherited short QT syndrome. Ann Noninvasive Electrocardiol 13(3):295–300PubMedPubMedCentral

61.

Anttonen O, Junttila MJ, Maury P, Schimpf R, Wolpert C, Borggrefe M et al (2009) Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval. Heart Rhythm 6(2):267–271PubMed

62.

Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf R, Sbragia P et al (2006) Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 27(20):2440–2447PubMed

63.

Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al (2005) Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111(5):659–670PubMed

64.

Antzelevitch C (2006) Brugada syndrome. Pacing Clin Electrophysiol 29(10):1130–1159PubMedPubMedCentral

65.

Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR (1999) The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 33(1):5–15PubMed

66.

Lukas A, Antzelevitch C (1996) Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. Cardiovasc Res 32(3):593–603PubMed

67.

Morita H, Zipes DP, Fukushima-Kusano K et al (2008) Repolarization heterogeneity in the right ventricular outflow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model. Heart Rhythm 5(5):725–733PubMed

68.

Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U et al (2002) Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105(11):1342–1347PubMed

69.

Brugada P, Brugada R, Brugada J (2005) Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 112(2):279–292 (discussion 279–292)PubMed

70.

Brugada J, Brugada R, Brugada P (2003) Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 108(25):3092–3096PubMed

71.

Watanabe H, Koopmann TT, Le Scouarnec S, Yang T, Ingram CR, Schott J‑J et al (2008) Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 118(6):2260–2268PubMedPubMedCentral

72.

Szél T, Antzelevitch C (2014) Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome. J Am Coll Cardiol 63(19):2037–2045PubMedPubMedCentral

73.

Postema PG, van Dessel PFHM, de Bakker JMT et al (2008) Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study. Circ Arrhythm Electrophysiol 1(5):379–386PubMed

74.

Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko DV, Nesterenko VV et al (1999) Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 85(9):803–809PubMed

75.

Ströker E, de Asmundis C, Chierchia G‑B, Brugada P (2016) Exercise-related Brugada pattern and monomorphic ventricular tachycardia in a patient with Brugada syndrome: interplay between body temperature, haemodynamics and vagal activity. Eur Heart J 37(7):655PubMed

76.

Cheung CC, Laksman ZWM, Mellor G, Sanatani S, Krahn AD (2016) Exercise and inherited arrhythmias. Can J Cardiol 32(4):452–458PubMed

77.

Hayashi M, Denjoy I, Extramiana F et al (2009) Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 119(18):2426–2434PubMed

78.

Napolitano C, Priori SG (2007) Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 4(5):675–678PubMed

79.

Mohamed U, Napolitano C, Priori SG (2007) Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 18(7):791–797PubMed

80.

Wehrens XHT (2007) The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms? Heart Rhythm 4(6):794–797PubMed

81.

Wilde AAM, Bhuiyan ZA, Crotti L et al (2008) Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 358(19):2024–2029PubMed

82.

Cerrone M, Napolitano C, Priori SG (2009) Catecholaminergic polymorphic ventricular tachycardia: a paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation. Heart Rhythm 6(11):1652–1659PubMed

83.

Manotheepan R, Danielsen TK, Sadredini M et al (2016) Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release. Cardiovasc Res 111(3):295–306PubMedPubMedCentral

84.

Noseworthy PA, Tikkanen JT, Porthan K, Oikarinen L, Pietilä A, Harald K et al (2011) The early repolarization pattern in the general population: clinical correlates and heritability. J Am Coll Cardiol 57(22):2284–2289PubMedPubMedCentral

85.

Tikkanen JT, Junttila MJ, Anttonen O, Aro AL, Luttinen S, Kerola T et al (2011) Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome. Circulation 123(23):2666–2673PubMed

86.

Kui C, Congxin H, Xi W, Yan-hong T, Okello E, Salim M et al (2008) Characteristic of the prevalence of J wave in apparently healthy Chinese adults. Arch Med Res 39(2):232–235PubMed

87.

Haruta D, Matsuo K, Tsuneto A, Ichimaru S, Hida A, Sera N et al (2011) Incidence and prognostic value of early repolarization pattern in the 12-lead electrocardiogram. Circulation 123(25):2931–2937PubMed

88.

Obeyesekere MN, Klein GJ, Nattel S, Leong-Sit P, Gula LJ, Skanes AC et al (2013) A clinical approach to early repolarization. Circulation 127(15):1620–1629PubMed

89.

Yan GX, Antzelevitch C (1996) Cellular basis for the electrocardiographic J wave. Circulation 93(2):372–379PubMed

90.

Koncz I, Gurabi Z, Patocskai B, Panama BK, Szél T, Hu D et al (2014) Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome. J Mol Cell Cardiol 68:20–28PubMed

91.

Antzelevitch C (2012) Genetic, molecular and cellular mechanisms underlying the J wave syndromes. Circ J 76(5):1054–1065PubMedPubMedCentral

92.

Haïssaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L et al (2008) Sudden cardiac arrest associated with early repolarization. N Engl J Med 358(19):2016–2023PubMed

93.

Noseworthy PA, Weiner R, Kim J, Keelara V, Wang F, Berkstresser B et al (2011) Early repolarization pattern in competitive athletes: clinical correlates and the effects of exercise training. Circ Arrhythm Electrophysiol 4(4):432–440PubMedPubMedCentral

94.

Heidbuchel H, Carre F (2014) Exercise and competitive sports in patients with an implantable cardioverter-defibrillator. Eur Heart J 35(44):3097–3102PubMed

95.

Sousa J, Kou W, Calkins H, Rosenheck S, Kadish A, Morady F (1992) Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. Am J Cardiol 69(5):509–512PubMed

96.

Drezner JA, Chun JSDY, Harmon KG, Derminer L (2008) Survival trends in the United States following exercise-related sudden cardiac arrest in the youth: 2000–2006. Heart Rhythm 5(6):794–799PubMed

97.

Heidbüchel H (2007) Implantable cardioverter defibrillator therapy in athletes. Cardiol Clin 25(3):467–482PubMed

98.

Francis J, Antzelevitch C (2008) Atrial fibrillation and Brugada syndrome. J Am Coll Cardiol 51(12):1149–1153PubMedPubMedCentral

99.

Bordachar P, Reuter S, Garrigue S, Caï X, Hocini M, Jaïs P et al (2004) Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J 25(10):879–884PubMed

100.

Veltmann C, Borggrefe M, Schimpf R, Wolpert C (2007) Fatal inappropriate ICD shock. J Cardiovasc Electrophysiol 18(3):326–328PubMed

101.

Zipes DP, Ackerman MJ, Estes NAM, Grant AO, Myerburg RJ, Van Hare G (2005) Task Force 7: arrhythmias. J Am Coll Cardiol 45(8):1354–1363PubMed

102.

Zipes DP, Link MS, Ackerman MJ et al (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. Circulation 132(22):e315–e325PubMed

103.

Zeigler VL, Decker-Walters B (2010) Determining psychosocial research priorities for adolescents with implantable cardioverter defibrillators using Delphi methodology. J Cardiovasc Nurs 25(5):398–404PubMed

104.

Rahman B, Macciocca I, Sahhar M et al (2012) Adolescents with implantable cardioverter defibrillators: a patient and parent perspective. Pacing Clin Electrophysiol 35(1):62–72PubMed

105.

Isaksen K, Morken IM, Munk PS, Larsen AI (2012) Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation. Eur J Prev Cardiol 19(4):804–812PubMed

106.

Law IH, Shannon K (2012) Implantable cardioverter-defibrillators and the young athlete: can the two coexist? Pediatr Cardiol 33(3):387–393PubMed

107.

Lampert R, Cannom D, Olshansky B (2006) Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members. J Cardiovasc Electrophysiol 17(1):11–15PubMed

108.

Maron BJ, Zipes DP (2008) It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports. Heart Rhythm 5(6):864–866PubMed

109.

Lampert R, Cannom D (2008) Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decision. Heart Rhythm 5(6):861–863PubMed

110.

Vanhees L, Kornaat M, Defoor J et al (2004) Effect of exercise training in patients with an implantable cardioverter defibrillator. Eur Heart J 25(13):1120–1126PubMed

111.

Deisenhofer I, Kolb C, Ndrepepa G et al (2001) Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 12(2):134–142PubMed

112.

Corrado D (2004) Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26(5):516–524

113.

Blom MT, Beesems SG, Homma PCM et al (2014) Improved survival after out-of-hospital cardiac arrest and use of automated external defibrillators. Circulation 130(21):1868–1875PubMed

114.

Priori SG, Blomström-Lundqvist C, Mazzanti A et al (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36(41):2793–2867PubMed

115.

Zipes DP, Ackerman MJ, Estes NA 3rd (2005) Task Force 7: arrhythmias. J Am Coll Cardiol 45(8):1354–1363PubMed

116.

Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al (2013) HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm 10(12):1932–1963PubMed

Titel: Inherited primary arrhythmia disorders: cardiac channelopathies and sports activity
verfasst von: S. Marrakchi
I. Kammoun
E. Bennour
L. Laroussi
M. Ben Miled
S. Kachboura
Publikationsdatum: 09.05.2018
Verlag: Springer Medizin
Erschienen in: Herz / Ausgabe 2/2020
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-018-4706-2

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Insufficient left ventricular unloading after extracorporeal membrane oxygenation

Erratum zu: Primärprävention der koronaren Herzkrankheit

Die antagonistische Funktion des Herzmuskels unterstützt die Autoregulation nach Frank-Starling

Grundlagen der Angiologie bei peripherer arterieller Verschlusskrankheit (pAVK)